Clinical Trial Update: Pharmacokinetic Evaluation of Empagliflozin [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetic evaluation of empagliflozin in participants with diabetes mellitus has completed, per a ClinicalTrials.gov update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Jardiance (empagliflozin)

Snippet

Sponsor: British University In Egypt | Conditions: Diabetes Mellitus | Phase 1 | Status: COMPLETED